ArticleJournal of neurology2026

Real-world neuropsychiatric safety profile of foslevodopa/foscarbidopa infusion in advanced Parkinson's disease.

Giulia Lazzeri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.